PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

BMS' Opdivo(nivolumab) Receives the US FDA's Approval for the Adjuvant Treatment of High-Risk Urothelial Carcinoma

BMS' Opdivo(nivolumab) Receives the US FDA's Approval for the Adjuvant Treatment of High-Risk Urothelial Carcinoma

August 23, 2021

BeiGene Reports NMPA's Acceptance of sBLA for Tislelizumab (BGB-A317) to Treat Nasopharyngeal Cancer in China

BeiGene Reports NMPA's Acceptance of sBLA for Tislelizumab (BGB-A317) to Treat Nasopharyngeal Cancer in China

August 23, 2021

Pfizer's Xeljanz (tofacitinib citrate) Receives EC's Approval for the Treatment of Active Polyarticular JIA & Juvenile PsA

Pfizer's Xeljanz (tofacitinib citrate) Receives EC's Approval for the Treatment of Active Polyarticular JIA & Juvenile PsA

August 23, 2021

Zydus' ZyCoV-D Receives the DCGI's EUA for the Treatment of COVID-19

Zydus' ZyCoV-D Receives the DCGI's EUA for the Treatment of COVID-19

August 23, 2021

Alexion to Discontinue its P-III CHAMPION-ALS Trial of Ultomiris (ravulizumab) for Amyotrophic Lateral Sclerosis

Alexion to Discontinue its P-III CHAMPION-ALS Trial of Ultomiris (ravulizumab) for Amyotrophic Lateral Sclerosis

August 23, 2021

Pfizer to Acquire Trillium for ~$2.26B

Pfizer to Acquire Trillium for ~$2.26B

August 23, 2021

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us